BioCentury
ARTICLE | Financial News

Biosimilars company Mabpharm sets sights on Hong Kong IPO

August 31, 2018 6:10 PM UTC

Mabpharm Ltd. (Taizhou, China) proposed Aug. 22 to list on the Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by CICC.

Mabpharm is the second biotechnology company this week to file to list on HKEX; Ascentage Pharma Group International (Suzhou, China) filed on Monday (see “Ascentage Hops in Hong Kong IPO Queue”)...